Cargando…
Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease
Cardiovascular disease remains one of the leading causes of death in China, with increasingly serious negative effects on people and society. Despite significant advances in preventing and treating cardiovascular diseases, such as atrial fibrillation/flutter and heart failure over the last few years...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846151/ https://www.ncbi.nlm.nih.gov/pubmed/36684578 http://dx.doi.org/10.3389/fcvm.2022.1037741 |
_version_ | 1784871096804179968 |
---|---|
author | Gong, Yuxuan Liu, Huaying Ke, Shen Zhuo, Li Wang, Haibin |
author_facet | Gong, Yuxuan Liu, Huaying Ke, Shen Zhuo, Li Wang, Haibin |
author_sort | Gong, Yuxuan |
collection | PubMed |
description | Cardiovascular disease remains one of the leading causes of death in China, with increasingly serious negative effects on people and society. Despite significant advances in preventing and treating cardiovascular diseases, such as atrial fibrillation/flutter and heart failure over the last few years, much more remains to be done. Therefore, developing innovative methods for identifying and managing cardiovascular disorders is critical. Nanomaterials provide multiple benefits in biomedicine, primarily better catalytic activity, drug loading, targeting, and imaging. Biomimetic materials and nanoparticles are specially combined to synthesize biomimetic nanoparticles that successfully reduce the nanoparticles’ toxicity and immunogenicity while enhancing histocompatibility. Additionally, the biological targeting capability of nanoparticles facilitates the diagnosis and therapy of cardiovascular disease. Nowadays, nanomedicine still faces numerous challenges, which necessitates creating nanoparticles that are highly selective, toxic-free, and better clinically applicable. This study reviews the scientific accomplishments in this field over the past few years covering the classification, applications, and prospects of noble metal biomimetic nanozymes and biomimetic nanocarriers. |
format | Online Article Text |
id | pubmed-9846151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98461512023-01-19 Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease Gong, Yuxuan Liu, Huaying Ke, Shen Zhuo, Li Wang, Haibin Front Cardiovasc Med Cardiovascular Medicine Cardiovascular disease remains one of the leading causes of death in China, with increasingly serious negative effects on people and society. Despite significant advances in preventing and treating cardiovascular diseases, such as atrial fibrillation/flutter and heart failure over the last few years, much more remains to be done. Therefore, developing innovative methods for identifying and managing cardiovascular disorders is critical. Nanomaterials provide multiple benefits in biomedicine, primarily better catalytic activity, drug loading, targeting, and imaging. Biomimetic materials and nanoparticles are specially combined to synthesize biomimetic nanoparticles that successfully reduce the nanoparticles’ toxicity and immunogenicity while enhancing histocompatibility. Additionally, the biological targeting capability of nanoparticles facilitates the diagnosis and therapy of cardiovascular disease. Nowadays, nanomedicine still faces numerous challenges, which necessitates creating nanoparticles that are highly selective, toxic-free, and better clinically applicable. This study reviews the scientific accomplishments in this field over the past few years covering the classification, applications, and prospects of noble metal biomimetic nanozymes and biomimetic nanocarriers. Frontiers Media S.A. 2023-01-04 /pmc/articles/PMC9846151/ /pubmed/36684578 http://dx.doi.org/10.3389/fcvm.2022.1037741 Text en Copyright © 2023 Gong, Liu, Ke, Zhuo and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Gong, Yuxuan Liu, Huaying Ke, Shen Zhuo, Li Wang, Haibin Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease |
title | Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease |
title_full | Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease |
title_fullStr | Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease |
title_full_unstemmed | Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease |
title_short | Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease |
title_sort | latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846151/ https://www.ncbi.nlm.nih.gov/pubmed/36684578 http://dx.doi.org/10.3389/fcvm.2022.1037741 |
work_keys_str_mv | AT gongyuxuan latestadvancesinbiomimeticnanomaterialsfordiagnosisandtreatmentofcardiovasculardisease AT liuhuaying latestadvancesinbiomimeticnanomaterialsfordiagnosisandtreatmentofcardiovasculardisease AT keshen latestadvancesinbiomimeticnanomaterialsfordiagnosisandtreatmentofcardiovasculardisease AT zhuoli latestadvancesinbiomimeticnanomaterialsfordiagnosisandtreatmentofcardiovasculardisease AT wanghaibin latestadvancesinbiomimeticnanomaterialsfordiagnosisandtreatmentofcardiovasculardisease |